Summary Of Loading Off Bottom - As At Close May 23.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
151
Summary Of Loading Off Bottom - As At Close May 23.

Bought at 1.4001 > 1.6000 [.0008]

Jan 15: 1,750

Total: 1,750

Bought at 1.2001 > 1.4000 [.0007]

Jan 15: 1,247

Total: 1,247

Bought at 1.0001 > 1.2000 [.0006]

Jan 15: 3,179

Total: 3,179

Bought at .8001 > 1.000 [.0005]

Jan 15: 2,484
Jan 16: 1,200
Jan 17: 1,330
Jan 18: 50

Total: 5,064

Bought at .6001 > .8000 [.0004]

Jan 15: 8,027
Jan 16: 2,411
Jan 17: 13,000
Jan 18: 235
Jan 22: 1,000

Total: 24,673

Bought at .4000 > .6000 [.0003]

Jan 18: 88,566
Jan 22: 16,500
Jan 23: 1,330
Jan 24: 300
Jan 25: 2,040
Jan 29: 6,319
Jan 30: 14,895 [all above .4200 - most around .4400]
Jan 31: 5,877
Feb 1: 8,100
Feb 4: 626
Feb 6: 230
Feb 7: 18,368
Feb 15: 674
Feb 19: 1,926 [all at .4200 / .4300]
Feb 20: 4,127 [all at .4425 > .4500]
Feb 22: 3,370 [.4500 / .4600 / .4999 / 2000 at .5267]
Feb 25: 25,902 [16,859 .4600 > .5000 / 5,660 .5200 > .5985]
Feb 26: 21,078 [18,778 .4750 > .4975 / 2,300 .5050 > .5500]
Feb 27: 10,350 [6,200 .4500 > .4780 / 1,250 .5100 > 5775]
Feb 28: 18,050 [11,500 .4600 > .4999 / 950 .5000 > .5999]
Mar 1: 6,981 [all .4060 / .4100 / .4600]
Mar 4: 200 [all .4900 / .5100]
Mar 5: 80 [all .5100]
Mar 6: 10,522 [7,800 - 73% .5100]
Mar 7: 200 [50% .4700 / 50% .5100]
Mar 8: 23,820 [19,900 .4450 > .4700 / 3,920 .5100]
Mar 11: 3,818 [.4000 / .4500 / .5000]
Mar 12: 7,390 [1,800 .4500 / 5,410 .5000/.5100]
Mar 13: 78,449 [0 < .4500 / 46,898 .4900 > .5800 / 10,300 .5500 > .5800]
Mar 14: 2,420 [.4950 / .5100 / .5200]
Mar 15: 11,638 [.4900 / .5399 / .5400]
Mar 18: 2,848 [1,000 .5000 / 1,000 .5100 / 650 .5300]
Mar 19: 1,155 [.5205/.5524]
Mar 20: 902 [.5350/.5400]
Mar 21: 6,200 [.5400/.5790]
Mar 22: 14,918 [5,580 .5100 > .5699]
Mar 25: 9,645 [.5100 > .5979 / 8,074 .5499 / .5500]
Mar 26: 6,975 [4,000 .4850 > .4979 / 2,825 .5017 > .5970]
Mar 27: 2,959 [1,000 .5500 / 1,303 .5950]
Mar 28: 10,384 [3,850 .5500 > .5620 / 4,384 .5900 > .5950]
Mar 29: 4,788 [4,200 .5600 > .5700]
Apr 1: 20,085 [1,169 .5474 > .5789 / 5,250 .5800 / 10,200 .5900 > .5999]
Apr 2: 5,744 [2,150 .5200 > .5499 / 2,698 .5500 > .5900]
Apr 3: 20,479 [5,045 .5300 > .5500 / 7,533 .5600 > .5790 / 5,499 .5999]
Apr 4: 15,848 [7,933 .5000 / 4,915 .5100 > .5400 / 3000 .5600]
Apr 5: 1,799 [all .5000 > .5290]
Apr 8: 6,740 [ all .5000 > .5700]
Apr 9: 1,712 [.5000 / .5400 / 1,000 .5700]
Apr 10: 20,802 [12,851, .5000 / 7,900 .51525 / .5250 / .5300]
Apr 11: 3,953 [all .5250]
Apr 12: 5,255 [1200 .5200 - remainder of ask retreated to .5850]
Apr 15: 5,296 [3,860 .5200]
Apr 16: 4,526 [3,700 .5100/.5250]
Apr 17: 15,970 [ 1,734 .5000 / 2,000 .5100 / 8,070 .5200 > .5400]
Apr 18: 2,400 [400 .5400/.5500 / 1,000 .5850]
Apr 22: 1,815 [1,010 .5300]
Apr 23: 5,711 [4,071 .4750 / 1,640 .5000 > .5300]
Apr 24: 3,678 [3,025 .4800 > .5000 hidden bid / 600 .5150 > .5400]
Apr 25: 875 [.4800 > .5100]
Apr 26: 8,333 [8,265 .5100]
Apr 29: 14,119 [.4500 hidden bid > .5700]
Apr 30: 3,080 [.4500 hidden bid > .5100]
May 1: 308 [.5100 > .5148]
May 2: 1,704 [hidden bid .4500 > .5350]
May 3: 323 [hidden bid .4500 > .5300]
May 6: 675 [hidden bid .4500]
May 7: 2,082 [hidden bid .4500 / 100 .5100 / 1,772 .5288 > .5300]
May 8: 2,036 [hidden bid .4500 / 1,981 .5100 > .5250]
May 9: 625 [hidden bid .4500 / 250 .5139 > .5200]
May 10: 14,022 [visible bid .4500 then .4600 > .5200]
May 13: 968 [hidden bid .4500 / .5100 > .5200]
May 14: 3,737 [hidden bid .4500 / 2,119 .5100 > .5200]
May 15: 1,845 [hidden bid .5000 / .5100]
May 16: 3,984 [hidden bid .5000 / .5150]
May 17: 250 [hidden bid .5000]
May 20: 924 [hidden bid .4550 / 823 .5100
May 22: 41 [hidden bid .4550]
May 23: 279 [hidden bid .4550]

Total: 618,020

Bought at .2310 > .3999:

Jan 15: 10,418 [all at .0380 - .0002 equivalent]
Jan 18: 22,269
Jan 23: 16,052 [mostly .0370/.0380/.3999]
Jan 24: 18,089 [mostly .0380/.0399]
Jan 25: 17,456 [mostly .0370/.0380]
Jan 28: 23,054 [mostly .0360/.0370/.0390]
Jan 29: 4,189 [mostly at .3900]
Jan 31: 3,001 [all around .3700]
Feb 1: 230 [at .0380]
Feb 4: 4,090 [all at .3800/.3825/.3900]
Feb 5: 6,334 [all at .3800/.3801/.3825]
Feb 6: 222 [all at .3800/.3801/.3813]
Feb 7: 3,144 [all at .3800/.3850]
Feb 8: 71,730 [mostly at .3400/.3800]
Feb 11: 19,719 [ask was .3300/.3400]
Feb 12: 763 [paint downs under ask .3300]
Feb 13: 13,675 [mostly at .3300 >.3425 - then none available < .4000]
Feb 14: 1,146 [all at .3350 > .4000 - then none available < .4200]
Feb 15: 6,608 [almost all at .3900 - then none available <.4300]
Feb 19: 7,356 [all at .3500 or 3837/.3975]
Feb 20: 1,200 [only 200/250/500 at .3025 > .3200]
Feb 21: 990 [only 830/55/105 at .3025 > .3100]
Feb 22: 4,567 [1 at .3100 open p/d - then .3250/.3420/.3480/.3500/.3550]
Mar 1: 5,500 [all .3900 / .3905]
Mar 4: 277 [all .3900]
Mar 5: 186 [all .3900]
Mar 6: 113 [.3900]
Mar 11: 1,125 [paints below extant .3900 bid]
Mar 12: 3,128 [paints below extant .3900 bid]

Total: 239,237

Assume following worst case prior from loading on January 14:

Bought at 1.000 [.0005]: 10,000 [20M] [estimate]

Bought at .8000 [.0004]: 23,000 [46M] [estimate]

Bought at .6000 [.0003]: 50,000 [100M] [estimate]

Bought at .4000 [.0002] 200,000 [400M] [estimate]

Total: 283,000 [566M] [precise]







Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading